tiprankstipranks
Trending News
More News >
Sartorius Stedim Biotech (FR:DIM)
:DIM
France Market

Sartorius Stedim Biotech (DIM) Financial Statements

Compare
18 Followers

Sartorius Stedim Biotech Financial Overview

Sartorius Stedim Biotech's market cap is currently €17.82B. The company's EPS TTM is €1.12; its P/E ratio is 67.07; and it has a dividend yield of 0.31%. Sartorius Stedim Biotech is scheduled to report earnings on February 3, 2026, and the estimated EPS forecast is €1.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 2.97B€ 2.78B€ 2.78B€ 3.49B€ 2.89B
Gross Profit€ 1.35B€ 1.21B€ 1.23B€ 1.82B€ 1.55B
Operating Income€ 549.00M€ 370.60M€ 484.50M€ 1.10B€ 912.67M
EBITDA€ 867.10M€ 670.50M€ 755.70M€ 1.33B€ 811.96M
Net Income€ 265.60M€ 175.10M€ 309.70M€ 876.10M€ 414.40M
Balance Sheet
Cash & Short-Term Investments€ 426.10M€ 688.80M€ 126.10M€ 133.00M€ 237.35M
Total Assets€ 8.02B€ 8.26B€ 7.74B€ 5.07B€ 3.95B
Total Debt€ 2.75B€ 2.87B€ 3.68B€ 1.14B€ 625.52M
Net Debt€ 2.32B€ 2.19B€ 3.57B€ 1.03B€ 401.89M
Total Liabilities€ 3.89B€ 4.23B€ 5.07B€ 2.55B€ 2.22B
Stockholders' Equity€ 4.09B€ 3.99B€ 2.64B€ 2.45B€ 1.66B
Cash Flow
Free Cash Flow€ 145.40M€ 475.30M€ 156.10M€ 181.70M€ 371.98M
Operating Cash Flow€ 538.60M€ 815.10M€ 629.70M€ 612.30M€ 695.97M
Investing Cash Flow€ -397.70M€ -340.00M€ -2.72B€ -957.50M€ -465.23M
Financing Cash Flow€ -389.20M€ 84.90M€ 1.99B€ 220.70M€ -69.27M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History

Sartorius Stedim Biotech Debt to Assets

Sartorius Stedim Biotech Cash Flow

Sartorius Stedim Biotech Forecast EPS vs Actual EPS